Physician profile
Stephanie Diana Crimmel
NPI 1174150411
$2,451.54
in general payments reported to CMS, 2019-2025
10 companies · $848 in 2025
The $848 reported for 2025 was more than what 89% of Critical Care Medicine (Anesthesiology) providers received nationally (typical 2025 total: $97.90).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,604 · 2025: $848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,032 · Travel and Lodging: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,031.55 |
| Travel and Lodging | $419.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $545.35 | 2024-2025 | Evoke |
| Abbott Laboratories | $512.26 | 2024-2025 | Proclaim |
| Nevro Corp. | $327.46 | 2024 | Senza |
| Mml US, INC. | $251.73 | 2024 | Reactiv8 |
| Spr Therapeutics, INC | $191.57 | 2024-2025 | Sprint Pns System |
| Averitas Pharma INC. | $151.58 | 2024 | Qutenza |
| Medtronic, INC. | $135.96 | 2024 | Intellis Adaptivestim |
| Biotronik Nro, INC. | $125.35 | 2024 | Prospera |
| Boston Scientific Corporation | $120.62 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Vertos Medical, INC. | $89.66 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Crimmel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.